Evidence map›Paper›PMID 32152322›Full record

ArticleNature communications2020

Minimal barriers to invasion during human colorectal tumor growth.

Marc D Ryser, Diego Mallo, Allison Hall, Timothy Hardman, Lorraine M King, Sergei Tatishchev, Inmaculada C Sorribes, Carlo C Maley, Jeffrey R Marks, E Shelley Hwang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Dormancy: There and Back Again.Molecular biology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Marc D RyserDepartment of Population Health Sciences, Duke University Medical Center, Durham, NC, USA. marc.ryser@duke.edu.
Diego MalloArizona Cancer Evolution Center and School of Life Sciences, Arizona State University, Tempe, AZ, USA.ORCID http://orcid.org/0000-0002-9046-8859
Allison HallDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Timothy HardmanDepartment of Surgery, Duke University Medical Center, Durham, NC, USA.
Lorraine M KingDepartment of Surgery, Duke University Medical Center, Durham, NC, USA.
Sergei TatishchevDepartment of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Inmaculada C SorribesDepartment of Mathematics, Duke University, Durham, NC, USA.
Carlo C MaleyArizona Cancer Evolution Center and School of Life Sciences, Arizona State University, Tempe, AZ, USA.ORCID http://orcid.org/0000-0002-0745-7076
Jeffrey R MarksDuke Cancer Institute, Durham, NC, USA.
E Shelley HwangDuke Cancer Institute, Durham, NC, USA.
Darryl ShibataDepartment of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. dshibata@usc.edu.
Duke Medical Center · USArizona State University · USDuke University · USUniversity of Southern California · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
Molecular, Cellular and Tissue Characterization UnitU2CCA233254 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY · 2018 to 2023
$11.4M
The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO, SHIBATA, DARRYL K · 2018 to 2022
$8.6M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)R01CA170595 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2012 to 2015
$2.1M
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCISR01CA185138 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY, MALEY, CARLO · 2014 to 2017
$2.0M
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer RiskR00CA207872 · NCI · DUKE UNIVERSITY · PI RYSER, MARC · 2018 to 2020
$746k
NCI NIH HHS P01 CA091955NCI NIH HHS P30 CA014236NCI NIH HHS R00 CA207872NCI NIH HHS R01 CA140657NCI NIH HHS R01 CA170595NCI NIH HHS R01 CA185138NCI NIH HHS U2C CA233254NCI NIH HHS U54 CA217376
6 · The paper itself

Abstract

Intra-tumoral heterogeneity (ITH) could represent clonal evolution where subclones with greater fitness confer more malignant phenotypes and invasion constitutes an evolutionary bottleneck. Alternatively, ITH could represent branching evolution with invasion of multiple subclones. The two models respectively predict a hierarchy of subclones arranged by phenotype, or multiple subclones with shared phenotypes. We delineate these modes of invasion by merging ancestral, topographic, and phenotypic information from 12 human colorectal tumors (11 carcinomas, 1 adenoma) obtained through saturation microdissection of 325 small tumor regions. The majority of subclones (29/46, 60%) share superficial and invasive phenotypes. Of 11 carcinomas, 9 show evidence of multiclonal invasion, and invasive and metastatic subclones arise early along the ancestral trees. Early multiclonal invasion in the majority of these tumors indicates the expansion of co-evolving subclones with similar malignant potential in absence of late bottlenecks and suggests that barriers to invasion are minimal during colorectal cancer growth.

Indexed as

Cell ProliferationClone CellsColorectal NeoplasmsGenotypeHumansMicrodissectionNeoplasm InvasivenessNeoplasm MicrometastasisPhenotype

Identifiers

PMID32152322
PMCPMC7062901
OpenAlexW3010545926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.